← Open Payments lookup

IVAN DANKANICH: Open Payments

NPI 1295182269 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$481 in 28 payments from 10 companies in 2025. Trend: 2023 $298 · 2024 $367 · 2025 $481

Food & beverage: $481
CompanyPaymentsAmount
Novo Nordisk Inc10$145
Amgen Inc.5$79
Lilly USA, LLC4$73
ABBVIE INC.2$48
Esperion Therapeutics, Inc.2$40
Astellas Pharma US Inc1$27
Corcept Therapeutics1$23
PFIZER INC.1$17
Dexcom, Inc.1$16
AstraZeneca Pharmaceuticals LP1$14

Products named: Ozempic, OTEZLA, MOUNJARO, VRAYLAR, NEXLETOL, Veozah, Korlym, ZEPBOUND.

Industry payments across FL — which companies pay providers there.